A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations | MicrobiomeTrials
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-02-25Est. Completion: 2027-09-03
Enrollment target: 150 participants
Locations
University of Arkansas for Medical Sciences (Site #208), Little Rock, Arkansas, United States
Profound Research LLC (Site #222), Carlsbad, California, United States
Collaborative Neuroscience Network - Los Alamitos- CenExel - PPDS (Site #217), Los Alamitos, California, United States
Keck Medicine of USC - USC Healthcare Center 2 (Site #221), Los Angeles, California, United States
Parkinson's Research Centers of America (Site #218), Palo Alto, California, United States
Rocky Mountain Clinical Research - CenExel - PPDS (Site #215), Englewood, Colorado, United States
Parkinson's Disease & Movement Disorders Center of Boca Raton (Site #227), Boca Raton, Florida, United States
UM-UHealth at Boca Raton (Site #226), Boca Raton, Florida, United States
Velocity Clinical Research - Hallandale Beach (Site #228), Hallandale, Florida, United States
University of Miami (Site #220), Miami, Florida, United States
Neurology One (Site #205), Orlando, Florida, United States
USF Parkinson's Disease and Movement Disorders Center (Site #206), Tampa, Florida, United States
Augusta University Medical Center (Site #212), Augusta, Georgia, United States
Other microbiome trials you might be interested in